fda compounded glp-1 is short-sighted on compounding GLP-1s FDA Shares Safety Data About

FDA approves olezarsen to reduce acute pancreatitis risk in severe hypertriglyceridemia by Bob Alaburda Tryngolza becomes the first therapy shown to lower the rate of acute pancreatitis in adults with triglycerides of at least 500 mg/dL, broadening an indication first granted for familial chylomicronemia syndrome in 2024

The figures below are total-blend micrograms

Cost considerations also influence regulatory decisions

The doctor meant well

What This Medical Weight Loss CME Course Covers GLP-1 Injectable Protocols Semaglutide (Wegovy, Ozempic) and tirzepatide (Zepbound, Mounjaro) prescribing, titration schedules, and side effect management

Diabetes (2005) 54(12):342734